Trial Profile
Prevalence and High rates of renal tubular damage in HBV monoinfected patients long-term treated with TDF in a real- life setting, a single centre trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Biomarker
- 10 Jul 2017 New trial record